Rocuronium

For a clinical pharmacist, rocuronium is an aminosteroid non-depolarizing neuromuscular blocking agent primarily used to facilitate tracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation.

Key Clinical Points

Mechanism of Action

  • Rocuronium competitively binds to nicotinic acetylcholine receptors at the motor end-plate, preventing acetylcholine from triggering muscle contraction, resulting in muscle paralysis without initial depolarization.
  • Onset and Duration: It has a rapid onset (clinical effect usually within 1-2 minutes) and an intermediate duration of action (typically 20 to 110 minutes depending on dose). It is faster in onset than vecuronium and other non-depolarizing agents but slower than succinylcholine.
  • Dosing: The ED95 (dose producing 95% twitch suppression) is about 0.3 mg/kg in adults; infants require slightly lower doses. Typical intubation doses range from 0.45 to 0.6 mg/kg, with higher doses (up to 2 mg/kg) used for rapid sequence induction.
  • Reversal: Rocuronium-induced neuromuscular blockade can be reversed by acetylcholinesterase inhibitors such as neostigmine, but more effectively and rapidly by sugammadex, a γ-cyclodextrin that encapsulates rocuronium molecules.
  • Metabolism and Excretion: It is primarily eliminated by the liver with a half-life of about 1 to 1.5 hours in adults and infants, and about 30% protein-bound.

Safety Considerations

  • Risk of allergic reactions, particularly in asthmatic patients, although incidence is similar to other non-depolarizing agents.
  • Causes complete paralysis including respiratory muscles; ventilatory support must be ensured after administration.
  • Safe for use in patients with malignant hyperthermia susceptibility, unlike depolarizing agents such as succinylcholine.

Clinical Uses

  • Facilitation of endotracheal intubation.
  • Muscle relaxation during surgery.
  • Facilitation of mechanical ventilation.
  • Sometimes used to stop muscle activity during seizures (though it has no anticonvulsant effect).

In summary, rocuronium is a widely used, rapid-onset, intermediate-duration non-depolarizing neuromuscular blocker with well-established dosing and reversal protocols, essential for surgical anesthesia and critical care muscle relaxation